Hong Kong · Delayed Price · Currency is HKD Alphamab Oncology Statistics
Total Valuation
HKG:9966 has a market cap or net worth of HKD 7.80 billion. The enterprise value is 6.45 billion.
| Market Cap | 7.80B |
| Enterprise Value | 6.45B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9966 has 968.51 million shares outstanding. The number of shares has decreased by -3.07% in one year.
| Current Share Class | 968.51M |
| Shares Outstanding | 968.51M |
| Shares Change (YoY) | -3.07% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 50.18% |
| Owned by Institutions (%) | 3.53% |
| Float | 482.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.04 |
| PB Ratio | 4.04 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.16.
| Current Ratio | 4.02 |
| Quick Ratio | 3.68 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -30.75 |
Financial Efficiency
Return on equity (ROE) is -9.98% and return on invested capital (ROIC) is -6.08%.
| Return on Equity (ROE) | -9.98% |
| Return on Assets (ROA) | -5.47% |
| Return on Invested Capital (ROIC) | -6.08% |
| Return on Capital Employed (ROCE) | -11.36% |
| Weighted Average Cost of Capital (WACC) | 7.15% |
| Revenue Per Employee | 1.16M |
| Profits Per Employee | -394,482 |
| Employee Count | 515 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.45% in the last 52 weeks. The beta is 0.56, so HKG:9966's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -35.45% |
| 50-Day Moving Average | 8.18 |
| 200-Day Moving Average | 8.80 |
| Relative Strength Index (RSI) | 54.62 |
| Average Volume (20 Days) | 968,951 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9966 had revenue of HKD 598.06 million and -203.16 million in losses. Loss per share was -0.21.
| Revenue | 598.06M |
| Gross Profit | 530.39M |
| Operating Income | -228.71M |
| Pretax Income | -203.16M |
| Net Income | -203.16M |
| EBITDA | -156.33M |
| EBIT | -228.71M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 1.65 billion in cash and 309.87 million in debt, with a net cash position of 1.34 billion or 1.39 per share.
| Cash & Cash Equivalents | 1.65B |
| Total Debt | 309.87M |
| Net Cash | 1.34B |
| Net Cash Per Share | 1.39 |
| Equity (Book Value) | 1.93B |
| Book Value Per Share | 1.99 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was -209.22 million and capital expenditures -17.95 million, giving a free cash flow of -227.17 million.
| Operating Cash Flow | -209.22M |
| Capital Expenditures | -17.95M |
| Depreciation & Amortization | 73.37M |
| Net Borrowing | -6.28M |
| Free Cash Flow | -227.17M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 88.69%, with operating and profit margins of -38.24% and -33.97%.
| Gross Margin | 88.69% |
| Operating Margin | -38.24% |
| Pretax Margin | -33.97% |
| Profit Margin | -33.97% |
| EBITDA Margin | -26.14% |
| EBIT Margin | -38.24% |
| FCF Margin | n/a |
Dividends & Yields
HKG:9966 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.07% |
| Shareholder Yield | 3.07% |
| Earnings Yield | -2.61% |
| FCF Yield | -2.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:9966 has an Altman Z-Score of 9.49 and a Piotroski F-Score of 1.
| Altman Z-Score | 9.49 |
| Piotroski F-Score | 1 |